An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum
Editorial by Prof Manolis Tsiknakis, Coordinator of ProCAncer-I project ProCAncer-I project after three years of implementation ProCAncer-I’s vision is to deliver a platform featuring a unique collection of PCa mpMRI images worldwide, in terms of data quantity,...
By Prof. Kai Vilanova. Chief MRI Department. Institute of Biomedical Research of Girona (IDIBGI) Clinical Challenge: Can artificial intelligence based mpMRI with clinical data predict prostate cancer recurrence after prostatectomy? Radical prostatectomy (RP) is a...
By Sara Colantonio, Researcher at ISTI-CNR AI trustworthiness in prostate cancer: where we stand Artificial intelligence (AI) is set to drive groundbreaking medical solutions and services that could transform the diagnosis and treatment in clinical pracise, with...
Interview with Dr. Giacomo Aringhieri, Radiology Research Fellow, Academic Radiology, Department of Translational Research, University of Pisa What is the experience of a young researcher in participating in a European project with great impact on healthcare like...
Partner presentation: Candiolo Cancer Institute, FPO – IRCCS The Candiolo Cancer Institute mission is to give significant contribution to fight cancer, by understanding the basics and providing state-of-the-art diagnostic and therapeutic services. The Institute works...
Partner presentation: CNR – National Research Council of Italy (CNR-ISTI and CNR-IFAC) The National Research Council (CNR) is the main public research organisation in Italy with the aim of carrying out, promoting, disseminating, transferring and improving research...
Newsletter #6 Contents
ProCAncer-I will organise a Dedicated Session on the project during the European Congress of Radiology 2025 on the 26th of February 2025, at 15.00-16.00, with the title "ProCAncer-I: an AI platform integrating multiparametric MRI and AI models" where we will present...
Harnessing Big Data for the Future of Healthcare: Innovative Solutions with EUCAIM, ProCAncer-I, and European Health Data Spaces
Harnessing Big Data for the Future of Healthcare: Innovative Solutions with EUCAIM, ProCAncer-I, and European Health Data Spaces
The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices were discussed at the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24). The congress took place from the 7th to 10th of November 2024...